Results

1–2 of 2 results for Emily Y. Chew

Phase 3 Randomized Studies of Efficacy and Safety of Revakinagene Taroretcel Producing Ciliary Neurotrophic Factor (CNTF) in Macular Telangiectasia Type 2
Emily Y. Chew, MD
Annual Meeting Talks
2023
Ten-Year Follow-up Data From the AREDS2 Study
Emily Y. Chew, MD
Updates from the Field
2021